Abstract:Apoptosis is the programmed cell death pathway that is critical for maintaining homeostasis, in which cancer cells can evade to ensure survival. For pharmaceutical drug discovery, it is important to characterize and compare different cancer therapeutics (i.e., small molecules, antibody drugs, cell therapies) that can initiate the process of apoptosis, enabling the identification of potential therapeutic candidates. In this work, we developed and demonstrated a multiplex detection method for monitoring apoptosis and necrosis with Annexin V, Caspase-3, and Propidium Iodide (PI) using the Cellaca® PLX Image Cytometer (Revvity Health Sciences, Inc., Lawrence, MA). First, apoptosis was induced in Jurkat and K562 cell lines with staurosporine over the course of 24 h, where apoptosis and necrosis were assessed at 0, 1, 1.5, 2, 4, 20, and 24 h timepoints. Samples were stained with Hoechst 33342 (total dye), Annexin V-APC (early-stage apoptosis), Caspase-3 488 (late-stage apoptosis), and PI (necrosis) at each timepoint and evaluated using image cytometry. Results showed that apoptotic factors and cascades were successfully detected along the pathway from early- to late-stage apoptosis, and ultimately necrosis. A clear trend was observed analyzing apoptotic and necrotic populations during the first 1.5 h, showing differences of up to ~15% in single Annexin V+ and Caspase-3+ populations in treated Jurkat cells, however, a significant increase in double positive apoptotic/necrotic cells for Annexin V+PI+ and Capase-3+PI+ was not observed until 20 h. Upon further analysis between apoptotic populations only, Annexin V+ only populations were higher than Caspase-3+ only populations by up to ~20% between 0 and 1.5 h. Conversely, K562 cells did not exhibit a notable change in apoptotic and necrotic populations due to low sensitivity to staurosporine. The proposed image cytometric detection method may provide an effective and efficient tool for rapid and reliable simultaneous detection of early- late-stage apoptosis, and necrosis. Therefore, allowing researchers to better characterize and screen potential cancer therapeutic drug candidates for their treatment efficacy in a higher throughput manner.

ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis

Recent Advances in Engineered Nanomaterials for Acute Kidney Injury Theranostics

An Activatable Near-Infrared Fluorescence Probe for in Vivo Imaging of Acute Kidney Injury by Targeting Phosphatidylserine and Caspase-3

Renal viability evaluated by the multiprobe assembly: a unique tool for the assessment of renal ischemic injury

Fluorimetric Tool to Discriminate Glomerular and Tubular Injuries In Vivo

Molecular imaging of neurodegeneration by a novel cross-disease biomarker

TUNEL Assay: A Powerful Tool for Kidney Injury Evaluation

Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury

An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injury

A NIR fluorescent probe for the detection of renal damage based on overrepresentation of alanine aminopeptidase enzyme

TUNEL-n-DIFL Method for Detection and Estimation of Apoptosis Specifically in Neurons and Glial Cells in Mixed Culture and Animal Models of Central Nervous System Diseases and Injuries

Label-free, real-time monitoring of cytochrome C drug responses in microdissected tumor biopsies with a multi-well aptasensor platform

Plasma proteomics of acute tubular injury

Cell-specific image-guided transcriptomics identifies complex injuries caused by ischemic acute kidney injury in mice

A Multiplex Assay to Simultaneously Monitor Apoptosis and Necrosis Using the Cellaca® PLX Image Cytometer

Rapid and non-invasive renal injury diagnosis unlocked by a glimpse into urinary protein particle size and charge

A nephron model for study of drug-induced acute kidney injury and assessment of drug-induced nephrotoxicity

Optical Molecular Probes for Imaging and Early Diagnosis of Acute Kidney Injury

Early diagnostic biomarkers for acute kidney injury using cisplatin-induced nephrotoxicity in rat model

Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review

Cysteine as an Innovative Biomarker for Kidney Injury